Amedeo Smart

Free Medical Literature Service



HIV Infection

  Free Subscription

Articles published in
PLoS Med
    September 2021
  1. FORD N, Eshun-Wilson I, Ameyan W, Newman M, et al
    Future directions for HIV service delivery research: Research gaps identified through WHO guideline development process.
    PLoS Med. 2021;18:e1003812.
    >> Share

  2. HICKEY MD, Ayieko J, Owaraganise A, Sim N, et al
    Effect of a patient-centered hypertension delivery strategy on all-cause mortality: Secondary analysis of SEARCH, a community-randomized trial in rural Kenya and Uganda.
    PLoS Med. 2021;18:e1003803.
    >> Share

  3. HERCE ME, Chagomerana MB, Zalla LC, Carbone NB, et al
    Community-facility linkage models and maternal and infant health outcomes in Malawi's PMTCT/ART program: A cohort study.
    PLoS Med. 2021;18:e1003780.
    >> Share

  4. MACPHERSON P, Webb EL, Kamchedzera W, Joekes E, et al
    Computer-aided X-ray screening for tuberculosis and HIV testing among adults with cough in Malawi (the PROSPECT study): A randomised trial and cost-effectiveness analysis.
    PLoS Med. 2021;18:e1003752.
    >> Share

  5. BASTOS ML, Melnychuk L, Campbell JR, Oxlade O, et al
    The latent tuberculosis cascade-of-care among people living with HIV: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003703.
    >> Share

  6. AULD AF, Kerkhoff AD, Hanifa Y, Wood R, et al
    Derivation and external validation of a risk score for predicting HIV-associated tuberculosis to support case finding and preventive therapy scale-up: A cohort study.
    PLoS Med. 2021;18:e1003739.
    >> Share

  7. UPPAL A, Rahman S, Campbell JR, Oxlade O, et al
    Economic and modeling evidence for tuberculosis preventive therapy among people living with HIV: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003712.
    >> Share

  8. YANES-LANE M, Ortiz-Brizuela E, Campbell JR, Benedetti A, et al
    Tuberculosis preventive therapy for people living with HIV: A systematic review and network meta-analysis.
    PLoS Med. 2021;18:e1003738.
    >> Share

  9. OXLADE O, Rochon H, Campbell JR, Menzies D, et al
    Tuberculosis preventive treatment in people living with HIV-Is the glass half empty or half full?
    PLoS Med. 2021;18:e1003702.
    >> Share

    June 2021
  10. HANUM N, Cambiano V, Sewell J, Rodger AJ, et al
    Trends in HIV incidence between 2013-2019 and association of baseline factors with subsequent incident HIV among gay, bisexual, and other men who have sex with men attending sexual health clinics in England: A prospective cohort study.
    PLoS Med. 2021;18:e1003677.
    >> Share

  11. CELUM C, Hosek S, Tsholwana M, Kassim S, et al
    PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: Results from HPTN 082, a randomized controlled trial.
    PLoS Med. 2021;18:e1003670.
    >> Share

  12. DE LAY PR, Benzaken A, Karim QA, Aliyu S, et al
    Ending AIDS as a public health threat by 2030: Time to reset targets for 2025.
    PLoS Med. 2021;18:e1003649.
    >> Share

    May 2021
  13. ESHUN-WILSON I, Awotiwon AA, Germann A, Amankwaa SA, et al
    Effects of community-based antiretroviral therapy initiation models on HIV treatment outcomes: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003646.
    >> Share

  14. EHRENKRANZ P, Rosen S, Boulle A, Eaton JW, et al
    The revolving door of HIV care: Revising the service delivery cascade to achieve the UNAIDS 95-95-95 goals.
    PLoS Med. 2021;18:e1003651.
    >> Share

  15. KINUTHIA J, Ronen K, Unger JA, Jiang W, et al
    SMS messaging to improve retention and viral suppression in prevention of mother-to-child HIV transmission (PMTCT) programs in Kenya: A 3-arm randomized clinical trial.
    PLoS Med. 2021;18:e1003650.
    >> Share

  16. SATINSKY EN, Kakuhikire B, Baguma C, Rasmussen JD, et al
    Adverse childhood experiences, adult depression, and suicidal ideation in rural Uganda: A cross-sectional, population-based study.
    PLoS Med. 2021;18:e1003642.
    >> Share

  17. CATTAMANCHI A, Crowder R, Kityamuwesi A, Kiwanuka N, et al
    Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda.
    PLoS Med. 2021;18:e1003628.
    >> Share

  18. CHAMIE G, Kwarisiima D, Ndyabakira A, Marson K, et al
    Financial incentives and deposit contracts to promote HIV retesting in Uganda: A randomized trial.
    PLoS Med. 2021;18:e1003630.
    >> Share

  19. KATCHER T, Thimmesch R, Spitz A, Kulkarni L, et al
    Sexual and reproductive health information and referrals for resettled refugee women: A survey of resettlement agencies in the United States.
    PLoS Med. 2021;18:e1003579.
    >> Share

  20. SHADE SB, Kirby VB, Stephens S, Moran L, et al
    Outcomes and costs of publicly funded patient navigation interventions to enhance HIV care continuum outcomes in the United States: A before-and-after study.
    PLoS Med. 2021;18:e1003418.
    >> Share

  21. INDRAVUDH PP, Fielding K, Kumwenda MK, Nzawa R, et al
    Effect of community-led delivery of HIV self-testing on HIV testing and antiretroviral therapy initiation in Malawi: A cluster-randomised trial.
    PLoS Med. 2021;18:e1003608.
    >> Share

    April 2021
  22. CALDERWOOD CJ, Wilson JP, Fielding KL, Harris RC, et al
    Dynamics of sputum conversion during effective tuberculosis treatment: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003566.
    >> Share

  23. SHADE SB, Marseille E, Kirby V, Chakravarty D, et al
    Health information technology interventions and engagement in HIV care and achievement of viral suppression in publicly funded settings in the US: A cost-effectiveness analysis.
    PLoS Med. 2021;18:e1003389.
    >> Share

    March 2021
  24. JANSE VAN RENSBURG GH, Feucht UD, Makin J, le Clus N, et al
    Healthcare without borders: A cross-sectional study of immigrant and nonimmigrant children admitted to a large public sector hospital in the Gauteng Province of South Africa.
    PLoS Med. 2021;18:e1003565.
    >> Share

  25. KELLY HA, Chikandiwa A, Sawadogo B, Gilham C, et al
    Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
    PLoS Med. 2021;18:e1003528.
    >> Share

  26. BALCELLS ME, Rojas L, Le Corre N, Martinez-Valdebenito C, et al
    Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
    PLoS Med. 2021;18:e1003415.
    >> Share

  27. BOR J, Gage A, Onoya D, Maskew M, et al
    Variation in HIV care and treatment outcomes by facility in South Africa, 2011-2015: A cohort study.
    PLoS Med. 2021;18:e1003479.
    >> Share

    February 2021
  28. POLITCH JA, Cu-Uvin S, Moench TR, Tashima KT, et al
    Safety, acceptability, and pharmacokinetics of a monoclonal antibody-based vaginal multipurpose prevention film (MB66): A Phase I randomized trial.
    PLoS Med. 2021;18:e1003495.
    >> Share

  29. KOSS CA, Havlir DV, Ayieko J, Kwarisiima D, et al
    HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda.
    PLoS Med. 2021;18:e1003492.
    >> Share

    January 2021
  30. CHANG LW, Mbabali I, Hutton H, Amico KR, et al
    Novel community health worker strategy for HIV service engagement in a hyperendemic community in Rakai, Uganda: A pragmatic, cluster-randomized trial.
    PLoS Med. 2021;18:e1003475.
    >> Share

  31. MEFFERT SM, Neylan TC, McCulloch CE, Blum K, et al
    Interpersonal psychotherapy delivered by nonspecialists for depression and posttraumatic stress disorder among Kenyan HIV-positive women affected by gender-based violence: Randomized controlled trial.
    PLoS Med. 2021;18:e1003468.
    >> Share

  32. STELZLE D, Godfrey-Faussett P, Jia C, Amiesimaka O, et al
    Estimating HIV pre-exposure prophylaxis need and impact in Malawi, Mozambique and Zambia: A geospatial and risk-based analysis.
    PLoS Med. 2021;18:e1003482.
    >> Share

    December 2020
  33. RICKS S, Denkinger CM, Schumacher SG, Hallett TB, et al
    The potential impact of urine-LAM diagnostics on tuberculosis incidence and mortality: A modelling analysis.
    PLoS Med. 2020;17:e1003466.
    >> Share

  34. HAUSER A, Kusejko K, Johnson LF, Gunthard HF, et al
    Impact of scaling up dolutegravir on antiretroviral resistance in South Africa: A modeling study.
    PLoS Med. 2020;17:e1003397.
    >> Share

    November 2020
  35. SCULIER D, Wandeler G, Yerly S, Marinosci A, et al
    Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
    PLoS Med. 2020;17:e1003421.
    >> Share

  36. BAIK Y, Rickman HM, Hanrahan CF, Mmolawa L, et al
    A clinical score for identifying active tuberculosis while awaiting microbiological results: Development and validation of a multivariable prediction model in sub-Saharan Africa.
    PLoS Med. 2020;17:e1003420.
    >> Share

  37. PSIHOPAIDAS D, Cohen SM, West T, Avery L, et al
    Implementation science and the Health Resources and Services Administration's Ryan White HIV/AIDS Program's work towards ending the HIV epidemic in the United States.
    PLoS Med. 2020;17:e1003128.
    >> Share

  38. ASGARY R, Staderini N, Mthethwa-Hleta S, Lopez Saavedra PA, et al
    Evaluating smartphone strategies for reliability, reproducibility, and quality of VIA for cervical cancer screening in the Shiselweni region of Eswatini: A cohort study.
    PLoS Med. 2020;17:e1003378.
    >> Share

    October 2020
  39. ZHANG C, Koniak-Griffin D, Qian HZ, Goldsamt LA, et al
    Impact of providing free HIV self-testing kits on frequency of testing among men who have sex with men and their sexual partners in China: A randomized controlled trial.
    PLoS Med. 2020;17:e1003365.
    >> Share

  40. YAPA HM, De Neve JW, Chetty T, Herbst C, et al
    The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: Results of a stepped-wedge cluster-randomised controlled implementation trial.
    PLoS Med. 2020;17:e1003150.
    >> Share

  41. BERNARD CL, Rao IJ, Robison KK, Brandeau ML, et al
    Health outcomes and cost-effectiveness of diversion programs for low-level drug offenders: A model-based analysis.
    PLoS Med. 2020;17:e1003239.
    >> Share

    September 2020
  42. ABDULLAHI SA, Smelyanskaya M, John S, Adamu HI, et al
    Providing TB and HIV outreach services to internally displaced populations in Northeast Nigeria: Results of a controlled intervention study.
    PLoS Med. 2020;17:e1003218.
    >> Share

  43. AMSTUTZ A, Nsakala BL, Vanobberghen F, Muhairwe J, et al
    Switch to second-line versus continued first-line antiretroviral therapy for patients with low-level HIV-1 viremia: An open-label randomized controlled trial in Lesotho.
    PLoS Med. 2020;17:e1003325.
    >> Share

  44. BEATTIE TS, Smilenova B, Krishnaratne S, Mazzuca A, et al
    Mental health problems among female sex workers in low- and middle-income countries: A systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003297.
    >> Share

    August 2020
  45. SHARMA V, Leight J, Verani F, Tewolde S, et al
    Effectiveness of a culturally appropriate intervention to prevent intimate partner violence and HIV transmission among men, women, and couples in rural Ethiopia: Findings from a cluster-randomized controlled trial.
    PLoS Med. 2020;17:e1003274.
    >> Share

  46. MASKEW M, Brennan AT, Fox MP, Vezi L, et al
    A clinical algorithm for same-day HIV treatment initiation in settings with high TB symptom prevalence in South Africa: The SLATE II individually randomized clinical trial.
    PLoS Med. 2020;17:e1003226.
    >> Share

    July 2020
  47. ROY M, Bolton-Moore C, Sikazwe I, Mukumbwa-Mwenechanya M, et al
    Participation in adherence clubs and on-time drug pickup among HIV-infected adults in Zambia: A matched-pair cluster randomized trial.
    PLoS Med. 2020;17:e1003116.
    >> Share

  48. JONES AA, Gicas KM, Seyedin S, Willi TS, et al
    Associations of substance use, psychosis, and mortality among people living in precarious housing or homelessness: A longitudinal, community-based study in Vancouver, Canada.
    PLoS Med. 2020;17:e1003172.
    >> Share

    May 2020
  49. BROGER T, Nicol MP, Szekely R, Bjerrum S, et al
    Diagnostic accuracy of a novel tuberculosis point-of-care urine lipoarabinomannan assay for people living with HIV: A meta-analysis of individual in- and outpatient data.
    PLoS Med. 2020;17:e1003113.
    >> Share

  50. ROKX C, Borjas Howard JF, Smit C, Wit FW, et al
    Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    PLoS Med. 2020;17:e1003101.
    >> Share

  51. KERKHOFF AD, Sikombe K, Eshun-Wilson I, Sikazwe I, et al
    Mortality estimates by age and sex among persons living with HIV after ART initiation in Zambia using electronic medical records supplemented with tracing a sample of lost patients: A cohort study.
    PLoS Med. 2020;17:e1003107.
    >> Share

  52. KLEIN PW, Psihopaidas D, Xavier J, Cohen SM, et al
    HIV-related outcome disparities between transgender women living with HIV and cisgender people living with HIV served by the Health Resources and Services Administration's Ryan White HIV/AIDS Program: A retrospective study.
    PLoS Med. 2020;17:e1003125.
    >> Share

  53. MOODIE Z, Walsh SR, Laher F, Maganga L, et al
    Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
    PLoS Med. 2020;17:e1003117.
    >> Share

  54. TODD CS, Jones HE, Langwenya N, Hoover DR, et al
    Safety and continued use of the levonorgestrel intrauterine system as compared with the copper intrauterine device among women living with HIV in South Africa: A randomized controlled trial.
    PLoS Med. 2020;17:e1003110.
    >> Share

    April 2020
  55. FLOYD S, Shanaube K, Yang B, Schaap A, et al
    HIV testing and treatment coverage achieved after 4 years across 14 urban and peri-urban communities in Zambia and South Africa: An analysis of findings from the HPTN 071 (PopART) trial.
    PLoS Med. 2020;17:e1003067.
    >> Share

  56. CHAN SS, Chappel AR, Maddox KEJ, Hoover KW, et al
    Pre-exposure prophylaxis for preventing acquisition of HIV: A cross-sectional study of patients, prescribers, uptake, and spending in the United States, 2015-2016.
    PLoS Med. 2020;17:e1003072.
    >> Share

  57. KRETZSCHMAR MEE, van der Sande MAB
    Hepatitis B prevention: Can we learn from the response to HIV/AIDS?
    PLoS Med. 2020;17:e1003109.
    >> Share

  58. MCNAUGHTON AL, Lourenco J, Bester PA, Mokaya J, et al
    Hepatitis B virus seroepidemiology data for Africa: Modelling intervention strategies based on a systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003068.
    >> Share

    March 2020
  59. BULSTRA CA, Hontelez JAC, Giardina F, Steen R, et al
    Mapping and characterising areas with high levels of HIV transmission in sub-Saharan Africa: A geospatial analysis of national survey data.
    PLoS Med. 2020;17:e1003042.
    >> Share

  60. DOHERTY M, Power L, Petrova M, Gunn S, et al
    Illness-related suffering and need for palliative care in Rohingya refugees and caregivers in Bangladesh: A cross-sectional study.
    PLoS Med. 2020;17:e1003011.
    >> Share

  61. GRIFFIN A, Dempsey A, Cousino W, Avery L, et al
    Addressing disparities in the health of persons with HIV attributable to unstable housing in the United States: The role of the Ryan White HIV/AIDS Program.
    PLoS Med. 2020;17:e1003057.
    >> Share

  62. MARUKUTIRA T, Gray RT, Douglass C, El-Hayek C, et al
    Gaps in the HIV diagnosis and care cascade for migrants in Australia, 2013-2017: A cross-sectional study.
    PLoS Med. 2020;17:e1003044.
    >> Share

  63. PEZZI C, Lee D, Kumar GS, Kawasaki B, et al
    Health screenings administered during the domestic medical examination of refugees and other eligible immigrants in nine US states, 2014-2016: A cross-sectional analysis.
    PLoS Med. 2020;17:e1003065.
    >> Share

  64. KIM HY, Dobra A, Tanser F
    Migration and first-year maternal mortality among HIV-positive postpartum women: A population-based longitudinal study in rural South Africa.
    PLoS Med. 2020;17:e1003085.
    >> Share

  65. KUMAR GS, Pezzi C, Wien S, Mamo B, et al
    Health of Special Immigrant Visa holders from Iraq and Afghanistan after arrival into the United States using Domestic Medical Examination data, 2014-2016: A cross-sectional analysis.
    PLoS Med. 2020;17:e1003083.
    >> Share

  66. JANDA A, Eder K, Fressle R, Geweniger A, et al
    Comprehensive infectious disease screening in a cohort of unaccompanied refugee minors in Germany from 2016 to 2017: A cross-sectional study.
    PLoS Med. 2020;17:e1003076.
    >> Share

  67. STEWARD WT, Koester KA, Guze MA, Kirby VB, et al
    Practice transformations to optimize the delivery of HIV primary care in community healthcare settings in the United States: A program implementation study.
    PLoS Med. 2020;17:e1003079.
    >> Share

    February 2020
  68. FORD N, Geng E, Ellman T, Orrell C, et al
    Emerging priorities for HIV service delivery.
    PLoS Med. 2020;17:e1003028.
    >> Share

  69. LIENHARDT C, Nunn A, Chaisson R, Vernon AA, et al
    Advances in clinical trial design: Weaving tomorrow's TB treatments.
    PLoS Med. 2020;17:e1003059.
    >> Share

  70. HERMANS LE, Carmona S, Nijhuis M, Tempelman HA, et al
    Virological suppression and clinical management in response to viremia in South African HIV treatment program: A multicenter cohort study.
    PLoS Med. 2020;17:e1003037.
    >> Share

  71. LAHER F, Moodie Z, Cohen KW, Grunenberg N, et al
    Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
    PLoS Med. 2020;17:e1003038.
    >> Share

    December 2019
  72. GENG EH, Holmes CB, Moshabela M, Sikazwe I, et al
    Personalized public health: An implementation research agenda for the HIV response and beyond.
    PLoS Med. 2019;16:e1003020.
    >> Share

    November 2019
  73. KENNEDY MC, Hayashi K, Milloy MJ, Wood E, et al
    Supervised injection facility use and all-cause mortality among people who inject drugs in Vancouver, Canada: A cohort study.
    PLoS Med. 2019;16:e1002964.
    >> Share

  74. MARKS C, Borquez A, Jain S, Sun X, et al
    Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis.
    PLoS Med. 2019;16:e1002973.
    >> Share

    October 2019
  75. ODENY TA, Hughes JP, Bukusi EA, Akama E, et al
    Text messaging for maternal and infant retention in prevention of mother-to-child HIV transmission services: A pragmatic stepped-wedge cluster-randomized trial in Kenya.
    PLoS Med. 2019;16:e1002924.
    >> Share

  76. ELPHINSTONE RE, Weckman AM, McDonald CR, Tran V, et al
    Early malaria infection, dysregulation of angiogenesis, metabolism and inflammation across pregnancy, and risk of preterm birth in Malawi: A cohort study.
    PLoS Med. 2019;16:e1002914.
    >> Share

  77. BRIGDEN G, Nhung NV, Skrahina A, Ndjeka N, et al
    Advances in clinical trial design for development of new TB treatments-Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam.
    PLoS Med. 2019;16:e1002896.
    >> Share

  78. XU Y, Cancino-Munoz I, Torres-Puente M, Villamayor LM, et al
    High-resolution mapping of tuberculosis transmission: Whole genome sequencing and phylogenetic modelling of a cohort from Valencia Region, Spain.
    PLoS Med. 2019;16:e1002961.
    >> Share

  79. MODY A, Eshun-Wilson I, Sikombe K, Schwartz SR, et al
    Longitudinal engagement trajectories and risk of death among new ART starters in Zambia: A group-based multi-trajectory analysis.
    PLoS Med. 2019;16:e1002959.
    >> Share

    September 2019
  80. LIENHARDT C, Vernon AA, Cavaleri M, Nambiar S, et al
    Development of new TB regimens: Harmonizing trial design, product registration requirements, and public health guidance.
    PLoS Med. 2019;16:e1002915.
    >> Share

  81. MUGWANYA KK, Pintye J, Kinuthia J, Abuna F, et al
    Integrating preexposure prophylaxis delivery in routine family planning clinics: A feasibility programmatic evaluation in Kenya.
    PLoS Med. 2019;16:e1002885.
    >> Share

  82. ROSEN S, Maskew M, Larson BA, Brennan AT, et al
    Simplified clinical algorithm for identifying patients eligible for same-day HIV treatment initiation (SLATE): Results from an individually randomized trial in South Africa and Kenya.
    PLoS Med. 2019;16:e1002912.
    >> Share

  83. AIBANA O, Huang CC, Aboud S, Arnedo-Pena A, et al
    Vitamin D status and risk of incident tuberculosis disease: A nested case-control study, systematic review, and individual-participant data meta-analysis.
    PLoS Med. 2019;16:e1002907.
    >> Share

  84. WAITT C, Orrell C, Walimbwa S, Singh Y, et al
    Safety and pharmacokinetics of dolutegravir in pregnant mothers with HIV infection and their neonates: A randomised trial (DolPHIN-1 study).
    PLoS Med. 2019;16:e1002895.
    >> Share

  85. DONALD KA, Wedderburn CJ, Barnett W, Nhapi RT, et al
    Risk and protective factors for child development: An observational South African birth cohort.
    PLoS Med. 2019;16:e1002920.
    >> Share

    August 2019
  86. GUPTA A, Hughes MD, Garcia-Prats AJ, McIntire K, et al
    Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons.
    PLoS Med. 2019;16:e1002882.
    >> Share

  87. SIKAZWE I, Eshun-Wilson I, Sikombe K, Czaicki N, et al
    Correction: Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    PLoS Med. 2019;16:e1002918.
    >> Share

  88. HOULE B, Rochat TJ, Newell ML, Stein A, et al
    Breastfeeding, HIV exposure, childhood obesity, and prehypertension: A South African cohort study.
    PLoS Med. 2019;16:e1002889.
    >> Share

    July 2019
  89. SCHUTZ C, Barr D, Andrade BB, Shey M, et al
    Clinical, microbiologic, and immunologic determinants of mortality in hospitalized patients with HIV-associated tuberculosis: A prospective cohort study.
    PLoS Med. 2019;16:e1002840.
    >> Share

  90. FOX MP, Pascoe S, Huber AN, Murphy J, et al
    Adherence clubs and decentralized medication delivery to support patient retention and sustained viral suppression in care: Results from a cluster-randomized evaluation of differentiated ART delivery models in South Africa.
    PLoS Med. 2019;16:e1002874.
    >> Share

    June 2019
  91. ROGERS VAN KATWYK S, Grimshaw JM, Nkangu M, Nagi R, et al
    Government policy interventions to reduce human antimicrobial use: A systematic review and evidence map.
    PLoS Med. 2019;16:e1002819.
    >> Share

  92. TYMEJCZYK O, Brazier E, Yiannoutsos CT, Vinikoor M, et al
    Changes in rapid HIV treatment initiation after national "treat all" policy adoption in 6 sub-Saharan African countries: Regression discontinuity analysis.
    PLoS Med. 2019;16:e1002822.
    >> Share

  93. ATUKUNDA EC, Mugyenyi GR, Obua C, Atuhumuza EB, et al
    Provision of family planning vouchers and early initiation of postpartum contraceptive use among women living with HIV in southwestern Uganda: A randomized controlled trial.
    PLoS Med. 2019;16:e1002832.
    >> Share

    May 2019
  94. GENG EH, Holmes CB
    Research to improve differentiated HIV service delivery interventions: Learning to learn as we do.
    PLoS Med. 2019;16:e1002809.
    >> Share

  95. EHRENKRANZ PD, Baptiste SL, Bygrave H, Ellman T, et al
    The missed potential of CD4 and viral load testing to improve clinical outcomes for people living with HIV in lower-resource settings.
    PLoS Med. 2019;16:e1002820.
    >> Share

  96. SIKAZWE I, Eshun-Wilson I, Sikombe K, Czaicki N, et al
    Retention and viral suppression in a cohort of HIV patients on antiretroviral therapy in Zambia: Regionally representative estimates using a multistage-sampling-based approach.
    PLoS Med. 2019;16:e1002811.
    >> Share

    April 2019
  97. GUPTA-WRIGHT A, Corbett EL, Wilson D, van Oosterhout JJ, et al
    Risk score for predicting mortality including urine lipoarabinomannan detection in hospital inpatients with HIV-associated tuberculosis in sub-Saharan Africa: Derivation and external validation cohort study.
    PLoS Med. 2019;16:e1002776.
    >> Share

  98. KAWASAKI M, Echiverri C, Raymond L, Cadena E, et al
    Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    PLoS Med. 2019;16:e1002780.
    >> Share

  99. MINERS A, Nadarzynski T, Witzel C, Phillips AN, et al
    Preferences for HIV testing services among men who have sex with men in the UK: A discrete choice experiment.
    PLoS Med. 2019;16:e1002779.
    >> Share

  100. PENN-NICHOLSON A, Hraha T, Thompson EG, Sterling D, et al
    Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.
    PLoS Med. 2019;16:e1002781.
    >> Share

  101. HANRAHAN CF, Nonyane BAS, Mmolawa L, West NS, et al
    Contact tracing versus facility-based screening for active TB case finding in rural South Africa: A pragmatic cluster-randomized trial (Kharitode TB).
    PLoS Med. 2019;16:e1002796.
    >> Share

  102. HUERGA H, Mathabire Rucker SC, Cossa L, Bastard M, et al
    Diagnostic value of the urine lipoarabinomannan assay in HIV-positive, ambulatory patients with CD4 below 200 cells/mul in 2 low-resource settings: A prospective observational study.
    PLoS Med. 2019;16:e1002792.
    >> Share

  103. GARCIA-PRATS AJ, Schaaf HS, Draper HR, Garcia-Cremades M, et al
    Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.
    PLoS Med. 2019;16:e1002789.
    >> Share

    March 2019
  104. BOGAARDS JA, Mooij SH, Xiridou M, Schim van der Loeff MF, et al
    Potential effectiveness of prophylactic HPV immunization for men who have sex with men in the Netherlands: A multi-model approach.
    PLoS Med. 2019;16:e1002756.
    >> Share

  105. GLADSTONE MJ, Chandna J, Kandawasvika G, Ntozini R, et al
    Independent and combined effects of improved water, sanitation, and hygiene (WASH) and improved complementary feeding on early neurodevelopment among children born to HIV-negative mothers in rural Zimbabwe: Substudy of a cluster-randomized trial.
    PLoS Med. 2019;16:e1002766.
    >> Share

  106. GELDSETZER P, Mboggo E, Larson E, Lema IA, et al
    Community health workers to improve uptake of maternal healthcare services: A cluster-randomized pragmatic trial in Dar es Salaam, Tanzania.
    PLoS Med. 2019;16:e1002768.
    >> Share

    February 2019
  107. BHATIA T, Enoch J, Khan M, Mathewson S, et al
    Setting targets for HIV/AIDS-What lessons can be learned from other disease control programmes?
    PLoS Med. 2019;16:e1002735.
    >> Share

  108. SUBBARAMAN R, Nathavitharana RR, Mayer KH, Satyanarayana S, et al
    Constructing care cascades for active tuberculosis: A strategy for program monitoring and identifying gaps in quality of care.
    PLoS Med. 2019;16:e1002754.
    >> Share

  109. BANDSMA RHJ, Voskuijl W, Chimwezi E, Fegan G, et al
    A reduced-carbohydrate and lactose-free formulation for stabilization among hospitalized children with severe acute malnutrition: A double-blind, randomized controlled trial.
    PLoS Med. 2019;16:e1002747.
    >> Share

    January 2019
  110. CHOKO AT, Corbett EL, Stallard N, Maheswaran H, et al
    HIV self-testing alone or with additional interventions, including financial incentives, and linkage to care or prevention among male partners of antenatal care clinic attendees in Malawi: An adaptive multi-arm, multi-stage cluster randomised trial.
    PLoS Med. 2019;16:e1002719.
    >> Share

  111. TENFORDE MW, Walker AS, Gibb DM, Manabe YC, et al
    Rapid antiretroviral therapy initiation in low- and middle-income countries: A resource-based approach.
    PLoS Med. 2019;16:e1002723.
    >> Share

  112. LOW AJ, Frederix K, McCracken S, Manyau S, et al
    Association between severe drought and HIV prevention and care behaviors in Lesotho: A population-based survey 2016-2017.
    PLoS Med. 2019;16:e1002727.
    >> Share

  113. JONES J, Sullivan PS, Curran JW
    Progress in the HIV epidemic: Identifying goals and measuring success.
    PLoS Med. 2019;16:e1002729.
    >> Share

    December 2018
  114. KITYO C, Szubert AJ, Siika A, Heyderman R, et al
    Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
    PLoS Med. 2018;15:e1002706.
    >> Share

  115. PLATT L, Grenfell P, Meiksin R, Elmes J, et al
    Associations between sex work laws and sex workers' health: A systematic review and meta-analysis of quantitative and qualitative studies.
    PLoS Med. 2018;15:e1002680.
    >> Share

  116. AMON JJ, Eba P, Sprague L, Edwards O, et al
    Defining rights-based indicators for HIV epidemic transition.
    PLoS Med. 2018;15:e1002720.
    >> Share

    November 2018
  117. LANDOVITZ RJ, Li S, Grinsztejn B, Dawood H, et al
    Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
    PLoS Med. 2018;15:e1002690.
    >> Share

  118. ALEXANDER KA, Heaney AK, Shaman J
    Hydrometeorology and flood pulse dynamics drive diarrheal disease outbreaks and increase vulnerability to climate change in surface-water-dependent populations: A retrospective analysis.
    PLoS Med. 2018;15:e1002688.
    >> Share

    October 2018
  119. LOELIGER KB, Meyer JP, Desai MM, Ciarleglio MM, et al
    Retention in HIV care during the 3 years following release from incarceration: A cohort study.
    PLoS Med. 2018;15:e1002667.
    >> Share

  120. GHYS PD, Williams BG, Over M, Hallett TB, et al
    Epidemiological metrics and benchmarks for a transition in the HIV epidemic.
    PLoS Med. 2018;15:e1002678.
    >> Share

    September 2018
  121. GELDSETZER P, Francis JM, Sando D, Asmus G, et al
    Community delivery of antiretroviral drugs: A non-inferiority cluster-randomized pragmatic trial in Dar es Salaam, Tanzania.
    PLoS Med. 2018;15:e1002659.
    >> Share

  122. VINCENT KL, Moss JA, Marzinke MA, Hendrix CW, et al
    Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial.
    PLoS Med. 2018;15:e1002655.
    >> Share

    August 2018
  123. FOX MP, Bor J, Brennan AT, MacLeod WB, et al
    Correction: Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.
    PLoS Med. 2018;15:e1002643.
    >> Share

  124. ZANOLINI A, Sikombe K, Sikazwe I, Eshun-Wilson I, et al
    Understanding preferences for HIV care and treatment in Zambia: Evidence from a discrete choice experiment among patients who have been lost to follow-up.
    PLoS Med. 2018;15:e1002636.
    >> Share

  125. TANG W, Wei C, Cao B, Wu D, et al
    Crowdsourcing to expand HIV testing among men who have sex with men in China: A closed cohort stepped wedge cluster randomized controlled trial.
    PLoS Med. 2018;15:e1002645.
    >> Share

    July 2018
  126. HARAUSZ EP, Garcia-Prats AJ, Law S, Schaaf HS, et al
    Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    PLoS Med. 2018;15:e1002591.
    >> Share

    June 2018
  127. MODY A, Sikazwe I, Czaicki NL, Wa Mwanza M, et al
    Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.
    PLoS Med. 2018;15:e1002574.
    >> Share

  128. FOX MP, Bor J, Brennan AT, MacLeod WB, et al
    Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.
    PLoS Med. 2018;15:e1002589.
    >> Share

  129. TORRONE EA, Morrison CS, Chen PL, Kwok C, et al
    Correction: Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
    PLoS Med. 2018;15:e1002608.
    >> Share

    May 2018
  130. DESMONDE S, Tanser F, Vreeman R, Takassi E, et al
    Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    PLoS Med. 2018;15:e1002565.
    >> Share

    March 2018
  131. PATEL P, Speight C, Maida A, Loustalot F, et al
    Integrating HIV and hypertension management in low-resource settings: Lessons from Malawi.
    PLoS Med. 2018;15:e1002523.
    >> Share

  132. SLOGROVE AL, Schomaker M, Davies MA, Williams P, et al
    The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
    PLoS Med. 2018;15:e1002514.
    >> Share

  133. MYER L, Phillips TK, Zerbe A, Brittain K, et al
    Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    PLoS Med. 2018;15:e1002547.
    >> Share

  134. STEKLER JD, Milne R, Payant R, Beck I, et al
    Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort.
    PLoS Med. 2018;15:e1002537.
    >> Share

  135. TYMEJCZYK O, Brazier E, Yiannoutsos C, Wools-Kaloustian K, et al
    HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
    PLoS Med. 2018;15:e1002534.
    >> Share

    February 2018
  136. TORRONE EA, Morrison CS, Chen PL, Kwok C, et al
    Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
    PLoS Med. 2018;15:e1002511.
    >> Share

  137. FRANCIS SC, Mthiyane TN, Baisley K, Mchunu SL, et al
    Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site.
    PLoS Med. 2018;15:e1002512.
    >> Share

    January 2018
  138. MARRAZZO JM, Dombrowski JC, Mayer KH
    Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement.
    PLoS Med. 2018;15:e1002485.
    >> Share

  139. HOLMES CB, Sikazwe I, Sikombe K, Eshun-Wilson I, et al
    Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based survey.
    PLoS Med. 2018;15:e1002489.
    >> Share

  140. GAUDINSKI MR, Coates EE, Houser KV, Chen GL, et al
    Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.
    PLoS Med. 2018;15:e1002493.
    >> Share

  141. JUDD A, Chappell E, Turkova A, Le Coeur S, et al
    Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    PLoS Med. 2018;15:e1002491.
    >> Share

    December 2017
  142. DUBE K, Sylla L, Dee L, Taylor J, et al
    Research on HIV cure: Mapping the ethics landscape.
    PLoS Med. 2017;14:e1002470.
    >> Share

  143. KENDALL EA, Schumacher SG, Denkinger CM, Dowdy DW, et al
    Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    PLoS Med. 2017;14:e1002472.
    >> Share

  144. SUTHAR AB, Barnighausen T
    Antiretroviral therapy and population mortality: Leveraging routine national data to advance policy.
    PLoS Med. 2017;14:e1002469.
    >> Share

  145. JOHNSON LF, May MT, Dorrington RE, Cornell M, et al
    Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
    PLoS Med. 2017;14:e1002468.
    >> Share

  146. CHESANG K, Hornston S, Muhenje O, Saliku T, et al
    Healthcare provider perspectives on managing sexually transmitted infections in HIV care settings in Kenya: A qualitative thematic analysis.
    PLoS Med. 2017;14:e1002480.
    >> Share

  147. WILSON E, Free C, Morris TP, Syred J, et al
    Internet-accessed sexually transmitted infection (e-STI) testing and results service: A randomised, single-blind, controlled trial.
    PLoS Med. 2017;14:e1002479.
    >> Share

  148. JOHNSTON C, Magaret A, Roychoudhury P, Greninger AL, et al
    Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.
    PLoS Med. 2017;14:e1002475.
    >> Share

    November 2017
  149. CASTILLO P, Hurtado JC, Martinez MJ, Jordao D, et al
    Validity of a minimally invasive autopsy for cause of death determination in maternal deaths in Mozambique: An observational study.
    PLoS Med. 2017;14:e1002431.
    >> Share

  150. MCNAIRY ML, Lamb MR, Gachuhi AB, Nuwagaba-Biribonwoha H, et al
    Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial.
    PLoS Med. 2017;14:e1002420.
    >> Share

  151. BOYD MA, Mocroft A, Ryom L, Monforte AD, et al
    Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
    PLoS Med. 2017;14:e1002424.
    >> Share

  152. HENRICH TJ, Hatano H, Bacon O, Hogan LE, et al
    HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    PLoS Med. 2017;14:e1002417.
    >> Share

  153. KAPLAN SR, Oosthuizen C, Stinson K, Little F, et al
    Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
    PLoS Med. 2017;14:e1002407.
    >> Share

  154. EL-SADR WM, Harripersaud K, Rabkin M
    Reaching global HIV/AIDS goals: What got us here, won't get us there.
    PLoS Med. 2017;14:e1002421.
    >> Share

  155. POTEAT T, Ackerman B, Diouf D, Ceesay N, et al
    HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis.
    PLoS Med. 2017;14:e1002422.
    >> Share

  156. MAYER KH, Seaton KE, Huang Y, Grunenberg N, et al
    Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
    PLoS Med. 2017;14:e1002435.
    >> Share

  157. SZUBERT AJ, Prendergast AJ, Spyer MJ, Musiime V, et al
    Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    PLoS Med. 2017;14:e1002432.
    >> Share

  158. MORRIS L, Mkhize NN
    Prospects for passive immunity to prevent HIV infection.
    PLoS Med. 2017;14:e1002436.
    >> Share

  159. KATZ IT, Kaplan R, Fitzmaurice G, Leone D, et al
    Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    PLoS Med. 2017;14:e1002434.
    >> Share

  160. ELUL B, Lamb MR, Lahuerta M, Abacassamo F, et al
    A combination intervention strategy to improve linkage to and retention in HIV care following diagnosis in Mozambique: A cluster-randomized study.
    PLoS Med. 2017;14:e1002433.
    >> Share

  161. BARNABAS RV, Celum C
    Closing the gaps in the HIV care continuum.
    PLoS Med. 2017;14:e1002443.
    >> Share

  162. DUNNING L, Francke JA, Mallampati D, MacLean RL, et al
    The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.
    PLoS Med. 2017;14:e1002446.
    >> Share

  163. CHANDA MM, Ortblad KF, Mwale M, Chongo S, et al
    HIV self-testing among female sex workers in Zambia: A cluster randomized controlled trial.
    PLoS Med. 2017;14:e1002442.
    >> Share

  164. EAKLE R, Gomez GB, Naicker N, Bothma R, et al
    HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    PLoS Med. 2017;14:e1002444.
    >> Share

  165. DEEKS SG, Lewin SR, Bekker LG
    The end of HIV: Still a very long way to go, but progress continues.
    PLoS Med. 2017;14:e1002466.
    >> Share

  166. BOR J, Fox MP, Rosen S, Venkataramani A, et al
    Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
    PLoS Med. 2017;14:e1002463.
    >> Share

  167. SOLOMON SS, McFall AM, Lucas GM, Srikrishnan AK, et al
    Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    PLoS Med. 2017;14:e1002460.
    >> Share

  168. ORTBLAD K, Kibuuka Musoke D, Ngabirano T, Nakitende A, et al
    Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial.
    PLoS Med. 2017;14:e1002458.
    >> Share

  169. CUMMINS NW, Rizza S, Litzow MR, Hua S, et al
    Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
    PLoS Med. 2017;14:e1002461.
    >> Share

  170. BEYRER C, Wirtz AL, O'Hara G, Leon N, et al
    The expanding epidemic of HIV-1 in the Russian Federation.
    PLoS Med. 2017;14:e1002462.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016